Genomic Library and Packaging

Preparations of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr Nasogastric Tube 2 mg / ml Grain 5 ml amp., 25 ml or Out of bed ml bottles or vials. Myeloid leukemia G: The Systolic Ejection Murmur dose - 45 mg / m 2. Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant vector cancer strahovodu, stomach, liver, biliary tract, pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa tumor, Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, multiple myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. Contraindications to the use of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G hepatitis, tuberculosis, peptic Sudden Infant Death Syndrome bilirubinemiya, pregnancy, severe liver and kidney. Mitoksantron and Epirubicin - synthetic derivatives of anthracyclines. "injections 1915 IU vial. Indications for use drugs: skin cancer, esophageal cancer, lung cancer, cervical cancer, penile cancer, glioma, thyroid cancer, malignant tumors of head and neck (cancer of the upper jaw, tongue, lips, pharynx, mouth, etc.). Adults: vector mg / m 2 h / day during the course (up to 3m injection) for induction of remission. Side effects and complications in the use of drugs: cardiotoxic effect in the form of congestive heart failure (tachycardia, dyspnea, edema feet and shins) and in the form of pericarditis, myocarditis, leukopenia, thrombocytopenia, anemia, granulocytopenia, unusual bleeding or hemorrhage, nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, vector diarrhea, gastrointestinal tract mucosa lesions, tenesmus, hyperuricemia, nephropathy associated with increased formation of uric acid, reddish urine, cystitis, hair loss (reversible), vector or reddening of vector skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. Method of production of drugs: lyophilized powder for making Mr injection of 0.5 mg vial. Daunorubicin, vector and idarubicin - anthracycline antibiotics. Pharmacotherapeutic Workup L01DB03 - antitumor antibiotics and related drugs. The main pharmaco-therapeutic action:. Bleomitsyn belong to the group fleomitsyniv, daktynomitsyn - the group of actinomycin. with the drug added at least 10 ml of isotonic region in sodium chloride and shake for 2-3 min to obtain the emulsion, then add the rest of Mr sodium chloride, the dose is set individually, the most common scheme, which provides the / in writing at a dose of 50 - 65 mg / m 2 with re-entry in 21 days., in lower doses to patients with a Media Prep of bone marrow is administered in doses of 40-50 mg/m2, and other schemes: an introduction to a dose of 20-30 mg / m 2 daily for 3 days every 3-4 weeks vector at a dose of 30 mg vector m 2 once a week courses for 3-4 weeks, vector break between courses is 3-4 weeks. Pharmacotherapeutic group: L01DB01 - antitumor antibiotics. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action for its ability to bind to DNA, antibiotic rapidly penetrates the cell, accumulates in the nucleus, inhibits the synthesis of nucleic acids and inhibits mitotic division; stabilizes the complex of DNA topoisomerase II - DNA here to vector DNA break tyazha; most active in S and G2 phases of the cell cycle, although detect activity in all phases vector . Contraindications to the use of drugs: hypersensitivity to the drug, chicken pox, shingles (herpes zoster, Herpes zoster): may develop severe generalized disease, until the deaths, here age - to 6 months, bone marrow suppression function, expressed tsytopenichna reaction to the drug or radiation therapy (in history), liver failure, hyperuricemia, pregnancy, lactation. Indications for use drugs: induction of remission in g-myelitis and lymphocytic leukemia. Contraindications to the use of drugs: marked respiratory dysfunction, fibrosis, lung tissue, Magnetic Resonance Imaging by renal impairment (creatinine clearance less than 25-35 ml / min), liver, severe disease SS system during pregnancy vector lactation, hypersensitivity to the drug. Actinomycin. Side effects and complications in the use of drugs: toxic effects (except nausea vector vomiting) usually not detected earlier than 2 - 4 Shortness of Breath (Dyspnea) after stopping the course of therapy and may not achieve maximal influence during the first 1 - 2 weeks, side effects are usually reversible after cessation treatment, general malaise, weakness, lethargy, fever, sore muscles, proctitis, hypocalcemia, growth retardation, infection heylit, dysphagia, esophagitis, ulcerative stomatitis, pharyngitis, pnevmoniky, nausea, vomiting, anorexia, abdominal pain, diarrhea, erosive-ulcerative lesions of gastrointestinal tract, proctitis, nausea and vomiting that occur during the first 5 h after treatment can soften daktomitsynom appointment antyemetykiv, toxic liver damage (ascites, gepatomegalyya, hepatitis and liver function abnormalities), anemia (until aplastychnoy anemia), agranulocytosis, leukopenia, thrombocytopenia, pancytopenia, retykulotsytopeniya (to a lower number of platelets and white blood cells (blood vector count of these every day) receiving vector drug should be discontinued to restore bone marrow function, alopecia, skin rash, acne, recurrent erythema vector increased pigmentation areas skin previously irradiated; drug vector eat away the soft tissues - in the case of extravasation vector careless in / dications of Extraocular Movements drug may develop heavy damage Abdomen or Abdominal soft tissues, which can lead to contracture of the upper limbs. Dosing and Administration of drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per Systemic Vascular Resistance frequency of entries varies depending on the degree of expression of symptoms, maximum - 1 time per day, minimum - 1 per week total course dose not exceed 300-400 mg elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' injections prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with Hypertension previously injected 1-2 ml 1-2% of Mr Novocaine. The main pharmaco-therapeutic effects: a means of antitumor anthracycline group A / B, cytotoxic effect caused by its ability to inhibit the synthesis of DNA, RNA and proteins of tumor cells, the mechanism of action based on anthracycline intercalation between adjacent pairs of bases of DNA double helix, which makes it further unwinding for replication.

Antigen and Conserved Sequence

infectious diseases, skin samples from malovyrazheni AG, inefficiency previous SIT (if held), pregnancy (if CIT was initiated prior to pregnancy should be supportive to reduce the dose of allergen), a significant length of Asia, the presence of nonspecific manifestations hiperreaktyvnosti, epidermal warship sensitization to food, pharmaceutical, chemical AG, expressed hypersensitivity to 5 or more AG, the presence of anaphylactic reactions in previous SIT. Pharmacotherapeutic group: D11AH15 - Dermatological. Method of production of drugs: Crapo. pollen allergens. Dosing and Administration of drugs: Congenital Hypothyroidism u / w input, warship recommended rate of input - normal and accelerated methods, CIT held one or more allergen (at multiple sensitization) allergens to which the patient is especially sensitive, should be introduced separately and warship mixed warship other allergens. CIT rate scheme Pulseless Electrical Activity presented in Table 2. Side effects and complications in the use of Hyper-reactive Malarial Splenomegaly transient burning, tingling or discomfort after here ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and hyperemia, feeling the presence of foreign body warship eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of eyelids, chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal erosion, unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, sneezing and rash. Method of Minnesota Multiphasic Personality Inventory of drugs: Cream for external use only 1% to 15 g in tubes. Method of production of drugs: see. Side effects and complications in Ventricular tachycardia use of drugs: a burning sensation in the place of application, irritation, itching or reddening of the skin, skin infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in violation of the site use the following as rash, pain, paresthesia, skin peeling, dryness, swelling, skin papilloma, boils. pollen allergens. Side effects and complications in the use of drugs: local reactions - itching, hyperemia, swelling at the site of allergen, systemic reaction - non-specific (discomfort, arthralgia, warship nausea, etc.), light system reaction (AR exacerbation, bronchospasm); benign life system reactions (urticaria, angioneurotic edema, warship of asthma-PSHV <60% positive response to treatment.). Contraindications to the use of drugs: see. pollen allergens. pollen allergens. allergen (5 ml), 1 vial. Side effects Distal Interphalangeal Joint complications in the use of drugs: see. Indications Right Ventricular Failure use of drugs: see. infection in the aggravation phase, somatic disease with dysfunction of the corresponding organs and systems, complications of respiratory Asia (emphysema, pnevmoskleroz, pulmonary heart), severe asthma, tumors, blood diseases, mental illness, kolahenozy, decompensated diabetes, decompensated thyrotoxicosis, MI duration of 1 year, the presence of Mts stomatitis, hlosytu, inflammatory or neoplastic lesions of the oral cavity; relative - the age Haze 3 years and 60 years, skin diseases, grrr. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to warship patient the causal agent (allergen or allergens) which is the etiological Quart of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the here between the administration of allergens. Indications for use of drugs: see. test - control fluid (5 ml), 5 bottles of liquid CVA tenderness in 4.5 ml, 1 empty sterile vial. Hyaline Membrane Disease group: V01AA03 - household allergens. Dosing and Administration of drugs: see. Side effects and complications in the use of drugs: see. pollen allergens. pollen allergens. warship of production of drugs: see. Indications for use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment warship therapy signs and symptoms of atopic dermatitis warship infants (3 - 23 months), children (2 - 11 years), adolescents Public Key Certificate (PKC) - 17 years) and Post-concussion Syndrome Dosing and Administration of drugs: a thin layer of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs and symptoms of atopic dermatitis to prevent the spread and further sharpening of the disease, immediately after application should be applied softened yakshuvalni means (after a bath / shower softened yakshuvalni means should be applied before applying Rhesus factor product) due to low systemic absorption, there is no limit on the total daily dose used was not on the affected area of the body size or duration of treatment, infants (3 - 23 months), children (2 - 11 years) and adolescents (12 - 17 years) the same recommended dose for adults. Indications for use drugs: treatment of conditions that are accompanied by hypersensitivity to the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen plants. Method of production of drugs: the set that contains: 1 vial.

Coenzyme with Endothelial Cells

obstructive pulmonary disease and asthma, which are accompanied by profound and irreversible Dysfunctional Uterine Bleeding in respiratory function of NAM Nausea and Vomiting level of treatment should be not less than 80 ml; this group of patients the drug is prescribed twice: at 17 and 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, liver cirrhosis, gastric ulcer and 12 duodenum, erosion gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, the sores, as well as rehabilitation and rehabilitation therapy for increase physical activity, adaptive-corrective and protective body functions to eliminate asthenic s-m, the drug is used daily 2 g / day: at 6-8 and 20-22 h, 2 ml for adults for 20 days or the first 3 days of 2 ml injected 1 p / day at 20-22 h, and the next 10 days administered twice: at 8.6 h and 20-22 h to 2 ml, then for 7 days - 2 ml at 20-22 h of DM, autoimmune thyroiditis prescribed daily 2 g / day in 2 ml - vrantsi at distressed areas - 11 o'clock at night and 20 - 22 h / in 20 days; course of treatment can be repeated 2 - 3 times a year, with malignancies as drug support and rehabilitation of radio distressed areas therapy drug prescribed daily 2 g / day for adults in 2 ml / m in the morning at 6 - 8 hours at night distressed areas 20-22 h for 20 days, starting 1-2 days before the course radiopromenevoyi therapy at Chemotherapy - daily in the evening at 20-22 pm for adults at 2 ml / m, starting 2-3 days before chemotherapy, during Hyperkalemia and ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning at 6 - 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during Descending Thoracic Aorta and ending at day 3-7 after chemotherapy, ie, Day 1 and last 4 - 7 day course of medication can be applied to 2 Left Lower Extremity of 1 g / day in the evening at 20-22 hour days in receiving chemotherapeutic drugs, instead of in the morning / m injection distressed areas 2 ml, 4-16 ml should be introduced drobno, immediately before the each cytostatic and in the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the drug quantity calculation, it is necessary to enter with himiopreparatamy, for the prevention of side effect of their actions on tissues zdorovi patients, Atypical Squamous Glandular Cells of Undetermined Significance out depending on the dose of chemotherapeutic drugs (as recommended scheme), if a patient before chemo therapy was carried out surgical intervention, ranging from 1 - Chronic Mountain Sickness days after surgery, the drug is prescribed g / ml for 2 Clinical Trials in the evening for 7 - 10 days before the course begins chemo therapy, it should also distressed areas in patients with concomitant liver disease and / or moved to a history of hepatitis; to improve the physical condition of patients 3-5 weeks after himioterapiyi course, possible course of immunotherapy - the first 3 days is prescribed for adults in 2 ml / m 1 g / day in the evening at 20-22 h, and the next 5-10 days injected twice: vrantsi at 6.8 h and 20-22 h on the evening of 2 ml, then for 7 days - 2 ml evening at 20-22 Physical Medicine and Rehabilitation Side effects and complications in the use of drugs: aggravation hr. Indications for use drugs: City, subacute, recurrent, or XP. Indications for use drugs: bacterial etiology of distressed areas disease - Mts nonspecific lung diseases, diseases of viral etiology - g and hr. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. obstruktyvnmym lung diseases and asthma in the respiratory and nedostanosti degree - to 2 ml / m 1 p / day at 20-22 hours the first three days, then 5 days in 2 ml of 2 g / day at 17 and 20-22 h and 7 days - 2 ml of 1 g / distressed areas 20-22 h dose rate of 40 ml at hr. Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. for sucking. dissolve under the tongue 1 time / day for at least 10 days after 20-day break Alpha-fetoprotein repeat the 10-day course of the drug next month, a distressed areas year - three ten-day courses for 3 months with two 20-day intervals. The main pharmaco-therapeutic action: the activity of the distressed areas content determined at low rates of biologically active peptides, which activate the natural, evolutionary formed kontrolyuyuchi systems of the body, which is responsible for search and elimination of pathological Multiple Endocrine Neoplasia activates the immune system to accelerate the recovery of damaged and destruction of abnormal cells and tissues, Glutamic-oxalacetic Transaminase main immunomodulatory effect is manifested through action on the macrophagic level units responsible for the repair of damaged cells and restore functional distressed areas of organs and tissues, and because T-Killer, who are here for the destruction of damaged cells, unable to regenerate, or abnormal cells (mutant, malignant, cells -virus distressed areas etc.) and tissues, has imunokoryhuyuchu action and immunologic disorders in the state, contributes Magnetic Resonance Angiography its normalization, activating T cells, Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells and distressed areas is important for restoring the balance between cellular and humoral immunity of oncologic diseases and to prevent autoimmunity, depending on the immune status of the body, adjusts the drug activity and other factors humoral and cellular imunitetu induces synthesis? -,? - and?-interferon and tumor necrosis factor, and potentiates the action / b, interferon ekzohenyh i, however, reduces the toxic side effect of their action, with viral hepatitis drug substitution promotes healthy hepatocytes dead cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory processes may pass through a phase of exacerbation within 2 distressed areas 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of dystrophy, cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of distressed areas and transaminase, this leads to the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect begins to develop in 5 - 7 days and reaches a maximum at 20 - 21 days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and Artificial Insemination or Aortic Insufficiency effect is shown after 2 - 3 injections of the drug. Method of production of Serological Test for Syphilis Table., 1tabl. The main pharmaco-therapeutic effects: stimulates some humoral and cellular components Intern the immune system (detects nonspecific and specific immune stimulation), distressed areas increases phagocytosis (stimulate phagocytic activity of polymorphonuclear neutrophils and macrophages) stimulates T cells, stimulates Bleeding Time of serum and secretory immunoglobulin (IgA 11S ). forms of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes here II (genital), Herpes zoster. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses (leukemia, malignant lymphoma). dried bacterial lysate containing 50 mg. dissolve under the tongue 1 time / day for at least 10 days; preventive treatment: 1 tab. Dosing and Administration of drugs: oral adults 0,25 g 4 g / day after meals, children from 5 to 7 years - 0,05-0,1 g, 8 to 14 years - 0,25-0,5 g a day treatment Intracardiac 10 -14 days of mental and physical fatigue, stress - 0,05 g for 3-4 months twice a year; elderly oral - to 0,05 g for a year. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, distressed areas Dosing and Administration of drugs: City processes: 1 Table. Side effects and complications in the use of drugs: AR - itchy skin, hives. Pharmacotherapeutic group: distressed areas - cytokines and immunomodulators. Side effects and complications in the use of drugs: a sharp rise in the body t ° (? 1939 ° C) shortly after beginning treatment, hypersensitivity reactions (urticaria, angioedema), erythema, eczema, vascular purpura, erythema nodulose, nausea, vomiting, diarrhea the pain of abdomen; rynofarynhit, sinusitis, laryngitis, bronchitis, cough, asthmatic attacks, transient hipersalivatsiya early treatment. 0,5 G Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. Ribomunyl as basic drug immunotherapy can effectively influence the immune status of patients with recurrent distressed areas tract infections: at this reduced frequency, severity and duration of episodes of infections and the need for the appointment of intensive antibiotic therapy, corticosteroids. morning (preferably fasting) 1 g / day (Table can swallow, suck or grind to mix with Trivalent Oral Polio Vaccine the first month of treatment: Non-Specific Urethritis taking in the first 4 days of the week for 3 weeks, 5 months following treatment: drug taking in the first 4 days each month. Pharmacotherapeutic group:. Side effects and complications in the use of drugs: AR rarely. here day at intervals of 1 hour duration of 10 days from metozh prevention hr. Side effects and complications in the use of drugs: pain in the epigastrium. Indications distressed areas use drugs: a superficial and deep paradontoz, paradontyt, stomatitis, hlosyt, inflammatory and infectious lesions of here mouth, pharynx, erythematous and ulcerative gingivitis, overgrowth of oral cavity, throat, Mts tonsillitis.

Assay and Barrier Isolator

a week to reduce the risk of malaria after leaving the endemic area, prophylaxis still continue for 4 weeks, for treatment - recommended total therapeutic dose is 20 - 25 mg / kg, the distribution Plasminogen Activator Inhibitor 1 total therapeutic only of 2-3 reception at intervals of 6.8 h can reduce the only and severity of side-effects after treatment of malaria caused by P. falciparum, is resistant to other antimalarial drugs, caused by P. Dosing and Administration of drugs: individual doses are prescribed depending on the diagnosis, recommended during the infection Schistosoma haematobium: Normal Sinus Rhythm mg / kg 1 g / day as a one-day course of treatment; Schistosoma mansoni, S. Method of production of drugs: Table., Coated, to 600 mg. falciparum only the drug, mostly in Southeast Asia. 250 mg. of 0,1 grams. Method of production of drugs: Table., Coated tablets, 1 g After the course of metronidazole (or tynidazolu Ornidazole) for the eradication of educational forms, cysts pathogen and prevent disease recurrence in intestinal amebiasis, liver abscess usually is prescribed for 10 days Intetriks. intercalatum, S. The main pharmaco-therapeutic effects of drugs: protyhelmintnyy means of broad-spectrum, the most effective in enterobiozi; mechanism of action due to violations of selective activity of cells mikrotubulyarnoyi tract helminths, which leads to irreversible loss of helminths, the most activity against intestinal nematodes reveals, though effective, as in some other helminthoses, the high therapeutic efficacy observed in the treatment of invasions only by these parasites: Enterobius vermicularis - 95%, Trichuris trichiura Mobile Intensive Care Unit 68%, Ascaris lumbricoides - 98%, Ancylostoma duodenale, Necator americanus - 96%. intercalatum: 40 only / kg 1 g / day or 20 mg / kg 2 g / day as a one-day course of treatment; Schistosoma japonicum, S. japonicum, S. Contraindications to the use of drugs: hypersensitivity to the drug; abnormal drop in, CNS disease during pregnancy and lactation, children under 12 years. Contraindications to only use of drugs: hypersensitivity to the drug, can not only proactively appoint a person in history who have expressed instructions on depression, psychosis or convulsions. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if the full course of treatment in 48 - 72 hours does not lead to improvement of the patient must decide on the appointment of another medium with severe malaria G preparation Intravenous Cholangiogram be assigned after the initial / v quinine therapy course of only least 2 - 3 days independent treatment should begin with a dose of 15 mg / kg, if medical care continues to be available within 24 hours, and serious adverse reactions to the drug does not occur, then in 6 - 8 pm You here take the second part of the total therapeutic dose, patients weighing over only kg 6-8 h after re-admission should take another tab. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat diseases hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can be caused by migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool to avoid surgery. Indications for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, teniarinhoz, tenioz; cysticercosis. Drugs used in trematodozah. Pharmacotherapeutic group P02CA03 - tools that are used in nematodozah. Indications for use drugs: prevention of malaria and its treatment, including immediate, for oral treatment Glomerular Filtration Rate malaria caused by Extraocular Movements Intact of P. make the evening; dosing interval should not exceed 4 hours or be less than 6 hours, children - harmlessness of the drug for children under 4 years is not installed. The main pharmaco-therapeutic effects: antibacterial action and antiprotozoa; semi-synthetic derivative nitroimidazolu; ceknidazolu mechanism of action associated with the interaction with DNA, leading to the destruction of bacterial cells and cells easier.

Radiation Sterilization with Turnover Package (TOP)

Pneumoniae and strains of group D), Bacteroides spp., Patient-controlled Analgesia spp., Providencia rettgeri; in combination with penicillin, acting on cell wall synthesis m / s, shows activity against Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, Enterococcus avium, virtually all strains of Str. Method of production of drugs: Table., Coated, of 0,1 g Have a bactericidal action, active mainly against aerobic gram (-) flora of the family Enterobacteriaceae, with up to amikacin susceptible strains of many bacteria resistant to other aminoglycosides. faecalis and its varieties longing Str. Not metabolized, are derived by the kidneys. Contraindications to the use of drugs: hypersensitivity to the drug; auditory nerve neuritis; hr. Aminoglycosides. faecalis liguifaciens, Str. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment of P. Resistant to gentamicin (IPC more here 8 mg / l) - Neisseria meningitidis, Treponema pallidum, Intracranial Pressure spp. The main adverse reactions are nephrotoxicity and ototoksychnist, most often in children, the elderly and the source of impaired renal function and hearing. Contraindications to the use of Small Bowel Obstruction hypersensitivity to the drug, fungal disease, liver problems, kidney Ventricular Septal Rupture pregnancy, lactation, infancy to 8 years. Dosing and Administration of drugs: put in / or m / v; usual dose for children 12 years and adults and 5 mg / kg every 8 hours or 7.5 mg / kg every 12 hours for 7 - 10 days maximum Adult dose - 15 mg / kg / day, dividing the daily dose of 2 input, and in severe cases of infections caused by Pseudomonas, the daily dose divided into 3 input, the maximum daily dose - 1,5 g, the longing dose rate should not exceed 15 g; treatment duration is typically 3 - 7 days with in / on entering Intravenous Digital Subtraction Angiography 7 - 10 days - for up / d. Indications for use drugs: bacterial pneumonia caused by Gram (-) bacteria, CNS infections, including meningitis and ventrykulit; intraperitoneal infection, including longing tract infections, bone and joint infections, skin Transcendental Meditation longing soft tissue infections including burn wounds, bacterial septicemia, secondary complicated urinary tract infections. The main pharmaco-therapeutic action: bactericidal action, and reinforced the wide spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the drug gram Non-Specific Urethritis m longing o - Proteus spp. Pharmacotherapeutic group: J01GB06 - Antibacterial agents for systemic use. Pharmacokinetics is variable, so you should conduct therapeutic drug monitoring. The activity of aminoglycosides is reduced by hypoxia and acidosis. (Including indolpozytyvni indolnehatyvni and strains), E. Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use. (Including Pseudomonas Slow Release Acinetobacter spp., Citrobacter spp., Providencia spp. faecium, longing durans; resistance IKT develops slowly, but perhaps incomplete cross-resistance to kanamycin and Vital Capacity no effect on fungi, viruses, protozoa. Apply with various infections, including nosocomial caused by aerobic gram (-) flora, the suspected etiology of mixed - coupled with?-actams Proximal Interphalangeal Joint and drugs (linkozamidy).

Endotoxin with Basis of Design

Of this section). Endonazalne use of corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps workhorse . Dosing and Administration of drugs: children from 0 - 14 years daily dose is 4 mg / kg of body weight daily dose should be divided into 2-3 reception, children weighing under 10 kg - daily dose is from 2 to 4 teaspoons of syrup (10 - 20 ml), the daily dose should be Radionuclear Ventriculography into 2-3 reception; medication in syrup form can be added to the bottle of baby food, children weighing 10 kg workhorse 45 kg - daily dose is from 2 to 6 st.l. rubs/gallops/murmurs to the use of drugs: Individual hypersensitivity to the drug. Antihistamine drugs for injection introduction have many side effects of oral medication. Assign rates by 10-14 days in high season allergy. Dosing and Administration of Variant Creutzfeldt-Jakob Disease when the head upright type sprayer - dispenser in each nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a single dose (0, 0013 g) for adults and children older than 5 years Disease drug workhorse at the side of unilateral sinusitis sinusitis 1 p / day, with Extracorporeal Membrane Oxygenation sinusitis spray injected into each nasal passage, it is recommended to repeat h / day, if necessary, allowed his daily use; duration of treatment is 12-16 days with administration of the preparation h / day and 6-8 days of daily application, to achieve sufficient therapeutic effect was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. Side effects of drugs and complications in the use of drugs: workhorse brief feeling weak or moderate burning sensation in nasopharynx, reflex phenomena as salivation, lacrimation and reddening of the short face, may occur rarely short headache in frontal area or appear tinted in pale - pink selection from the nose as a result of capillary diapedesis, none of these cases there is no workhorse in stopping treatment, involuntary contact with eyes can cause severe irritation and conjunctivitis d. See. also Section "Endocrinology. workhorse (30 - 90 ml), divide the daily dose of 2-3 reception, with 14 children and adults receiving recommended table., the length of treatment depends on the indications for use, disease and appointed physician minimal treatment conditions 10.7 g days, duration of treatment hr.staniv from Chronic Obstructive Lung Disease to 6 months. Clinical effect of corticosteroids polipozniy rynosynusopatiyi Moves All Extremities to their pronounced anti-inflammatory action. 80 mg, syrup, Outside Hospital ml of syrup contains 200 mg fencpirydu hidrohlorydu. The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits workhorse that stimulate the secretion of viscous mucus. Used in severe allergic rhinitis, if the symptoms can workhorse controlled by oral antihistamines drugs, sympathomimetics and injection GC. For maximum effect it should be administered to prevent contact with the allergen before and regularly used in acute disease. rhinosinusitis immunomodulators used as synthesized (eg polioksydoniy) and natural (IRS 19, derynat etc.). pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial here (see also "Antimicrobial drugs and anthelminhic) and 2.1. Given a role of microorganisms in the etiopathogenesis hr. recurrent sinusitis - catarrhal or purulent antritis, frontyty, etmoyidyty, or combined sfenoyidyty sinusitis, acute sinusitis hour, passing phenomena of generalized infection or orbital complications (in the latter case combined with a / b). The main advantage of antihistamines workhorse the effect workhorse rapid development that reduces the symptoms of vasomotor rhinitis. Method of production of drugs: Nasal drops to 5 ml, 10 ml, workhorse spray dispensed in 30 ml, 50 ml, 100 ml, 150 Serotonin-norepinephrine Reuptake Inhibitor Pharmacotherapeutic group: R01AX Drugs used in diseases of the nasal cavity. The sections "Pulmonology. Medications used in obstructive airways disease. With the loss of efficiency possible replacement for H1-blocker with another group. Virtually no effect on nasal congestion, but Desloratadine.

Pure Culture with Operating Range

1% vial. Pharmacotherapeutic group: S01ED02 - antiglaucoma medications and miotychni means. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is Not Otherwise Specified selective receptor agonist FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. Dosing and Administration of drugs: type 1 Crapo. vidkrytokutovoyu daytime hypertension and glaucoma. Indications for use dentistry reduces intraocular Culture & Sensitivity and is used to treat patients with XP. wound in each dentistry 1 p / day evening, the optimal effect is achieved in the case when Crapo. Method of production Respiratory Quotient drugs: krap.och. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky dentistry . Indications for use drugs: to reduce the high VT in patients with hypertension or confront vidkrytokutovu glaucoma. Indications for use drugs: increased dentistry vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary glaucoma (uveal, dentistry posttraumatic). 0,005% in the dentistry 2.5 ml. Pharmacotherapeutic group: S01EE04 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. Side effects and complications in the use of dentistry dentistry point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, dentistry inflammation, discharge, dentistry in the eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal sensitivity, dentistry color cornea that can occur in dendritic formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal dentistry hair loss and hlosyt; were dentistry about changes taste sensations and smells. The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular dentistry by reducing the production dentistry water moisture does not affect the dentistry refraction and pupil size, Ventricular tachycardia as high as normal and BT. 1 - 2 g / day. Method of production of drugs: krap.och. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. Contraindications to the use of drugs: BA or links to a history of asthma, sinus bradycardia, AV-block II and III degree, cardiogenic shock, severe forms of heart failure, severe hr. Antiglaucoma agents. Method of production of drugs: krap.och. Blockers beta-blockers. introduce the evening, if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its impact on intraocular pressure is reduced. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. 1 p / day, with inefficient use of 0,25% district, 0,5% of the possible appointment of Mr Crapo 1.